Literature DB >> 21039952

Gilles de la Tourette syndrome and deep brain stimulation.

Marwan I Hariz1, Mary M Robertson.   

Abstract

Gilles de la Tourette Syndrome (GTS) is characterized by multiple motor and one or more vocal/phonic tics. Psychopathology and co-morbidity occur in approximately 80-90% of clinical cohorts. The most common psychopathologies are attention deficit hyperactivity disorder, obsessive-compulsive behaviours, obsessive-compulsive disorder, depression, anxiety and certain behavioural disorders. In severe GTS patients who are refractory to medication and other therapies, deep brain stimulation (DBS) is investigated. To date there have been some 50-55 patients who have received DBS in 19 centres worldwide. Nine different brain targets in the thalamus, the pallidum, and the ventral caudate and anterior internal capsule have been stimulated. This paper reviews critically and in detail all studies published to date. Only two studies on just a few patients fulfil some of the evidence-based criteria. DBS for GTS is therefore still highly experimental.
© 2010 The Authors. European Journal of Neuroscience © 2010 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21039952     DOI: 10.1111/j.1460-9568.2010.07415.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  23 in total

1.  Why so many deep brain stimulation targets in Tourette's syndrome? Toward a broadening of the definition of the syndrome.

Authors:  Mauro Porta; Christian Saleh; Edvin Zekaj; Carlotta Zanaboni Dina; Alberto R Bona; Domenico Servello
Journal:  J Neural Transm (Vienna)       Date:  2016-01-06       Impact factor: 3.575

2.  Centromedian-parafascicular deep brain stimulation induces differential functional inhibition of the motor, associative, and limbic circuits in large animals.

Authors:  Joo Pyung Kim; Hoon-Ki Min; Emily J Knight; Penelope S Duffy; Osama A Abulseoud; Michael P Marsh; Katherine Kelsey; Charles D Blaha; Kevin E Bennet; Mark A Frye; Kendall H Lee
Journal:  Biol Psychiatry       Date:  2013-08-30       Impact factor: 13.382

3.  Successful pallidal deep brain stimulation in 15-year-old with Tourette syndrome: 2-year follow-up.

Authors:  João Massano; Cláudia Sousa; Tom Foltynie; Ludvic Zrinzo; Marwan Hariz; Rui Vaz
Journal:  J Neurol       Date:  2013-07-25       Impact factor: 4.849

Review 4.  [Deep brain stimulation for hyperkinetic movement disorders].

Authors:  M M Reich; J Volkmann
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

5.  Deep-Brain Stimulation for Basal Ganglia Disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Basal Ganglia       Date:  2011-07-01

Review 6.  Toward sophisticated basal ganglia neuromodulation: Review on basal ganglia deep brain stimulation.

Authors:  Claudio Da Cunha; Suelen L Boschen; Alexander Gómez-A; Erika K Ross; William S J Gibson; Hoon-Ki Min; Kendall H Lee; Charles D Blaha
Journal:  Neurosci Biobehav Rev       Date:  2015-02-12       Impact factor: 8.989

7.  Bilateral deep brain stimulation of the nucleus accumbens for comorbid obsessive compulsive disorder and Tourette's syndrome.

Authors:  Perminder Singh Sachdev; Elisabeth Cannon; Terry J Coyne; Peter Silburn
Journal:  BMJ Case Rep       Date:  2012-09-12

8.  Deep brain stimulation of the amygdala alleviates fear conditioning-induced alterations in synaptic plasticity in the cortical-amygdala pathway and fear memory.

Authors:  Li Sui; SiJia Huang; BinBin Peng; Jie Ren; FuYing Tian; Yan Wang
Journal:  J Neural Transm (Vienna)       Date:  2014-03-09       Impact factor: 3.575

Review 9.  Toward Electrophysiology-Based Intelligent Adaptive Deep Brain Stimulation for Movement Disorders.

Authors:  Andrea A Kühn; R Mark Richardson; Wolf-Julian Neumann; Robert S Turner; Benjamin Blankertz; Tom Mitchell
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

Review 10.  Wireless neurochemical monitoring in humans.

Authors:  Aimen Kasasbeh; Kendall Lee; Allan Bieber; Kevin Bennet; Su-Youne Chang
Journal:  Stereotact Funct Neurosurg       Date:  2013-02-27       Impact factor: 1.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.